Mark Gelder
Plus aucun poste en cours
Profil
Mark Stephen Gelder worked as an Executive Medical Director, Chief Medical Officer, Vice President of Medical Affairs & Oncology, and Vice President of Clinical Development in various pharmaceutical companies such as Labcorp Drug Development, Heron Therapeutics, Onconova Therapeutics, Accelovance, and Inovio Pharmaceuticals.
He also served as the Chief Medical Officer at Elevar Therapeutics and Pierian Biosciences LLC.
Gelder completed his undergraduate degree at Colgate University and earned his doctorate from The University of Virginia School of Medicine.
Anciens postes connus de Mark Gelder
| Sociétés | Poste | Fin |
|---|---|---|
| TRAWS PHARMA, INC. | Directeur Technique/Scientifique/R&D | 06/04/2023 |
Elevar Therapeutics, Inc.
 Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Corporate Officer/Principal | 01/06/2021 |
| COVANCE INC. | Corporate Officer/Principal | 01/05/2020 |
| HERON THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 23/01/2015 |
Pierian Biosciences LLC
 Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Corporate Officer/Principal | - |
Formation de Mark Gelder
| Colgate University | Undergraduate Degree |
| The University of Virginia School of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HERON THERAPEUTICS, INC. | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Accelovance, Inc.
 Accelovance, Inc. Miscellaneous Commercial ServicesCommercial Services Accevolance, Inc. engages in providing clinical research and development services. It operates through the following core service divisions: Full-Service CRO, Patient Recruitment, and Clinical Call Center. The Full-Service CRO division includes protocol development, project management, clinical trial monitoring, data management, Biostatistics, Pharmacovigilance, regulatory affairs, and medical writing. The Patient Recruitment division involves patient recruitment and management. The Clinical Call Center division provides recruitment, retention, and compliance; post approval safety studies; Phase IV studies; surveillance programs; patient-reported outcomes; observational studies; registries; site support services; patient market research; and risk management support. The company was founded by Stephen J. Trevisan in 2005 and is headquartered in Rockville, MD. | Commercial Services |
Elevar Therapeutics, Inc.
Elevar Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elevar Therapeutics, Inc. engages in the provision of biopharmaceutical services. It offers Rivoceranib, a small-molecule angiogenesis inhibitor in gastric cancer that use in the growth and proliferation in cancer cells. The company was founded by Sung Chul Kim and Soo Whan Choi in 2005 and is headquartered in Salt Lake City, UT. | Health Technology |
Pierian Biosciences LLC
Pierian Biosciences LLC Medical/Nursing ServicesHealth Services Pierian Biosciences LLC operates as a diagnostic development and laboratory service company. It offers ChemoINTEL, a functional multi-parametric chemosensitivity assay measuring the real-time kinetic molecular and morphologic apoptotic response in isolated tumor cells; and ImmunoINTEL, a flow cytometry-based platform delivering phenotypic characterization and quantitative functional interrogation of tumor and immune populations within a tumor sample and relevant tissues. The company is headquartered in Franklin, TN. | Health Services |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
